New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report.

Currado, D; Margiotta, Dpe; Conforti, C; Coppola, R; Panasiti, V; Afeltra, A; Navarini, L

Currado, D; Margiotta, Dpe; Conforti, C; Coppola, R; Panasiti, V; Afeltra, A; Navarini, L.

Afiliação

Currado D; Unit of Allergology, Immunology, Rheumatology, Department of Medicine, Campus Bio-Medico University of Rome, Rome, Italy.
Margiotta D; Unit of Allergology, Immunology, Rheumatology, Department of Medicine, Campus Bio-Medico University of Rome, Rome, Italy.
Conforti C; Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, Italy.
Coppola R; Unit of Plastic and Reconstructive Surgery, Sapienza University, Rome, Italy.
Panasiti V; Unit of Plastic and Reconstructive Surgery, Department of Medicine, Campus Bio-Medico University of Rome, Rome, Italy.
Afeltra A; Unit of Plastic and Reconstructive Surgery, Department of Medicine, Campus Bio-Medico University of Rome, Rome, Italy.
Navarini L; Unit of Allergology, Immunology, Rheumatology, Department of Medicine, Campus Bio-Medico University of Rome, Rome, Italy.

Scand J Rheumatol ; 49(1): 75-76, 2020 Jan.

Article em En | MEDLINE | ID: mdl-31262212

Assuntos

Anticorpos Monoclonais Humanizados/efeitos adversos; Psoríase/induzido quimicamente; Espondilite Anquilosante/tratamento farmacológico; Anticorpos Monoclonais Humanizados/administração & dosagem; Dermoscopia; Feminino; Humanos; Injeções Subcutâneas; Pessoa de Meia-Idade; Psoríase/diagnóstico; Pele/patologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Espondilite Anquilosante / Anticorpos Monoclonais Humanizados Tipo de estudo: Diagnostic_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Scand J Rheumatol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google